Finance

Lists
COYA:NASDAQ
Coya Therapeutics Inc
5,08 USD
-1,93%
(-0,100) 1D
25-сен., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COYA...
Open
5,19 USD
High
5,24 USD
Low
5,02 USD
Mkt. cap
119,17 млн
Avg. vol.
131,50 миң
Volume
59,94 миң
52-wk high
7,75 USD
52-wk low
3,71 USD
EPS
-1,07 USD
Beta
0,61
Shares outstanding
23,46 млн
No. of employees
8
Open
5,19 USD
High
5,24 USD
Low
5,02 USD
Mkt. cap
119,17 млн
Avg. vol.
131,50 миң
Volume
59,94 миң
52-wk high
7,75 USD
52-wk low
3,71 USD
EPS
-1,07 USD
Beta
0,61
Shares outstanding
23,46 млн
No. of employees
8
News stories
From web sources and news partners
About Coya Therapeutics Inc
CEO-
Employees8
Founded2020
HeadquartersХьюстон, Техас, Америка Кошмо Штаттары
Sector-
Websitecoyatherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to COYA in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for COYA in the last 3 months.
Highest
Current 5,08 USD
18,00 USD (+254,33%)
Average
15,33 USD (+201,77%)
Lowest
12,00 USD (+136,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
18,00 USD
+254,3%
09/25/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
12,00 USD
+136,2%
08/23/2026
Thomas Shrader
BTIG
Buy
Maintained
16,00 USD
+215%
08/11/2026
Chad Messer
Lake Street
Buy
Maintained
17,00 USD
+234,6%
05/22/2026
Keay Nakae
Chardan Capital
Buy
Maintained
14,00 USD
+175,6%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
3,56 млн
3,96 млн
251,15 миң
243,74 миң
Cost of goods sold
2,92 млн
4,94 млн
4,10 млн
-
Cost of revenue
2,92 млн
4,94 млн
4,10 млн
-
Research and development expenses
-
-
-
5,03 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,56 млн
3,27 млн
3,78 млн
2,26 млн
Operating expense
2,56 млн
3,28 млн
3,78 млн
7,29 млн
Total operating expenses
5,48 млн
8,22 млн
7,88 млн
7,29 млн
Operating income
-1,92 млн
-4,26 млн
-7,63 млн
-7,05 млн
Other non operating income
-
-
-
408,73 миң
EBT including unusual items
-2,12 млн
-5,71 млн
-7,21 млн
-6,64 млн
EBT excluding unusual items
-1,60 млн
-3,93 млн
-7,20 млн
-6,64 млн
Income tax expense
-
3,09 миң
-
-
Effective tax rate
-
-0,05%
-
-
Other operating expenses
-
-
-
-
Net income
-2,12 млн
-5,71 млн
-7,21 млн
-6,64 млн
Net profit margin
-59,36%
-144,16%
-2 869,63%
-2 723,44%
Earnings per share
-0,13
-0,34
-0,32
-0,28
Interest and investment income
317,07 миң
325,44 миң
433,23 миң
-
Interest expense
-
-
-
-
Net interest expenses
317,07 миң
325,44 миң
433,23 миң
-
Depreciation and amortization charges
6,84 миң
6,84 миң
2,81 миң
2,81 миң
EBITDA
-1,91 млн
-4,25 млн
-7,63 млн
-7,04 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору